Peter Altman - Net Worth and Insider Trading

Peter Altman Net Worth

The estimated net worth of Peter Altman is at least $247,268 dollars as of 2024-12-27. Peter Altman is the President and CEO of BioCardia Inc and owns about 106,581 shares of BioCardia Inc (BCDA) stock worth over $247,268. Details can be seen in Peter Altman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Altman has not made any transactions after 2024-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peter Altman

To

Peter Altman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Altman owns 1 companies in total, including BioCardia Inc (BCDA) .

Click here to see the complete history of Peter Altman’s form 4 insider trades.

Insider Ownership Summary of Peter Altman

Ticker Comapny Transaction Date Type of Owner
BCDA BioCardia Inc 2024-12-23 director & President and CEO

Peter Altman Latest Holdings Summary

Peter Altman currently owns a total of 1 stock. Peter Altman owns 106,581 shares of BioCardia Inc (BCDA) as of December 23, 2024, with a value of $247,268.

Latest Holdings of Peter Altman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCDA BioCardia Inc 2024-12-23 106,581 2.32 247,268

Holding Weightings of Peter Altman


Peter Altman Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Altman has made a total of 3 transactions in BioCardia Inc (BCDA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in BioCardia Inc is the acquisition of 1,000 shares on December 23, 2024, which cost Peter Altman around $2,060.

Insider Trading History of Peter Altman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Altman Trading Performance

GuruFocus tracks the stock performance after each of Peter Altman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Altman is -27.53%. GuruFocus also compares Peter Altman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Altman within 3 months outperforms 4 times out of 25 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter Altman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter Altman

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 26 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.34 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.35 LIMIT LIMIT LIMIT LIMIT LIMIT

Peter Altman Ownership Network

Ownership Network List of Peter Altman

No Data

Ownership Network Relation of Peter Altman

Insider Network Chart

Peter Altman Owned Company Details

What does BioCardia Inc do?

Who are the key executives at BioCardia Inc?

Peter Altman is the director & President and CEO of BioCardia Inc. Other key executives at BioCardia Inc include Senior Vice President & Devices Edward M Gillis , 10 percent owner Frost Phillip Md Et Al , and 10 percent owner Frost Gamma Investments Trust .

BioCardia Inc (BCDA) Insider Trades Summary

Over the past 18 months, Peter Altman made 3 insider transaction in BioCardia Inc (BCDA) with a net purchase of 2,600. Other recent insider transactions involving BioCardia Inc (BCDA) include a net sale of 129,802 shares made by Frost Phillip Md Et Al , a net sale of 3,257 shares made by Edward M Gillis ,

In summary, during the past 3 months, insiders sold 3,257 shares of BioCardia Inc (BCDA) in total and bought 2,600 shares, with a net sale of 657 shares. During the past 18 months, 11,910 shares of BioCardia Inc (BCDA) were sold and 2,600 shares were bought by its insiders, resulting in a net sale of 9,310 shares.

BioCardia Inc (BCDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioCardia Inc Insider Transactions

No Available Data

Peter Altman Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Altman. You might contact Peter Altman via mailing address: C/o Biocardia Inc, 125 Shoreway Road Suite B, San Carlos Ca 94070.

Discussions on Peter Altman

No discussions yet.